Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrave Bison Regulatory News (BBSN)

Share Price Information for Brave Bison (BBSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.525
Bid: 2.50
Ask: 2.55
Change: 0.00 (0.00%)
Spread: 0.05 (2.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.525
BBSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Brave Bison Group

15 Jun 2017 07:00

Media Partners Base79 Holdings LLC - Form 8.3 - Brave Bison Group

Media Partners Base79 Holdings LLC - Form 8.3 - Brave Bison Group

PR Newswire

London, June 15

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Media Partners Base79 Holdings LLC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeBrave Bison Group PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosureJune 13, 2017
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:Ordinary Shares of 0.1p
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:8,318,5631.56%00
(2) Cash-settled derivatives:0000
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:0000
TOTAL:8,318,5631.56%00

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:June 14, 2017
Contact name:Jennifer Gautier
Telephone number:+1-212-596-9173

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at http://www.thetakeoverpanel.org.uk/.

Date   Source Headline
22nd Apr 20247:00 amRNSFinal Results
10th Apr 20247:00 amRNSNotice of Results & Investor Presentation
15th Feb 20247:00 amRNSHolding(s) in Company
15th Feb 20247:00 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSTrading Update
14th Dec 20234:15 pmRNSChange of Registered Office
12th Dec 20232:30 pmRNSGrant of RSU's and Director/PDMR Shareholding
23rd Nov 202311:00 amRNSDirector/PDMR Shareholding
20th Nov 20235:00 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSDirector/PDMR Shareholding
13th Nov 20237:00 amRNSContract Wins & Investor Presentation
24th Oct 20235:15 pmRNSChange of Nominated Adviser and Broker
24th Oct 202312:30 pmRNSDirector/PDMR Shareholding
13th Sep 20237:00 amRNSHalf-year Report
4th Sep 20237:00 amRNSNotice of Results & Investor Presentation
29th Aug 202312:16 pmRNSHolding(s) in Company
15th Aug 202310:00 amRNSHolding(s) in Company
22nd Jun 20234:40 pmRNSHolding(s) in Company
14th Jun 20233:01 pmRNSResult of AGM
14th Jun 20237:00 amRNSAGM Statement
19th May 20237:00 amRNSNotice of AGM
10th May 20238:18 amRNSHolding(s) in Company
27th Apr 20237:00 amRNSFinal Results
19th Apr 20237:00 amRNSNotice of Results & Investor Presentation
10th Mar 20234:58 pmRNSHolding(s) in Company
9th Mar 202311:43 amRNSHolding(s) in Company
21st Feb 20231:34 pmRNSHolding(s) in Company
21st Feb 20231:33 pmRNSHolding(s) in Company
21st Feb 20231:32 pmRNSHolding(s) in Company
21st Feb 20231:30 pmRNSHolding(s) in Company
13th Feb 20235:50 pmRNSHolding(s) in Company
13th Feb 202310:23 amRNSHolding(s) in Company
7th Feb 20237:00 amRNSHolding(s) in Company
6th Feb 20235:28 pmRNSHolding(s) in Company
6th Feb 20235:04 pmRNSDirector/PDMR Shareholding
6th Feb 20231:06 pmRNSHolding(s) in Company
3rd Feb 20237:00 amRNSAcquisition of Social Chain and Vendor Placing
14th Dec 20224:17 pmRNSHolding(s) in Company
7th Dec 202211:17 amRNSHolding(s) in Company
7th Nov 20227:00 amRNSNew Financing Facility
22nd Sep 20227:00 amRNSHalf-year Report
16th Sep 20227:00 amRNSNotice of Interim Results & Investor Presentation
3rd Aug 20223:17 pmRNSHolding(s) in Company
22nd Jul 20221:55 pmRNSHolding(s) in Company
21st Jul 20227:00 amRNSHalf Year Trading Update
11th Jul 20227:00 amRNSDirectorate Change
29th Jun 20225:04 pmRNSResult of AGM
29th Jun 20227:00 amRNSAGM Statement
6th Jun 20227:00 amRNSSignificant Contract Wins
27th May 20224:21 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.